MRNA - Moderna, Inc. - SEC Form 4 Insider Trading Screener
100 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2020-08-05 | MRNA | Bancel Stephane | CEO | S - Sale | $76.61 | -19,000 | 24,116,613 | 0% | -$1,455,610 | |||||
| D | 2020-08-03 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $74.89 | -20,000 | 1,970,646 | -1% | -$1,497,800 | |||||
| D | 2020-08-03 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $74.89 | -20,000 | 0 | -100% | -$1,497,800 | |||||
| M | 2020-07-31 | MRNA | Bancel Stephane | CEO | S - Sale | $75.15 | -19,143 | 23,661,619 | 0% | -$1,438,545 | |||||
| M | 2020-07-29 | MRNA | Bancel Stephane | CEO | S - Sale | $79.88 | -19,000 | 24,155,756 | 0% | -$1,517,800 | |||||
| D | 2020-07-27 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $78.73 | -20,000 | 0 | -100% | -$1,574,524 | |||||
| DM | 2020-07-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.86 | -20,000 | 1,970,646 | -1% | -$1,577,102 | |||||
| DM | 2020-07-23 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $78.86 | -20,000 | 1,970,646 | -1% | -$1,577,102 | |||||
2020-07-24 | MRNA | Bancel Stephane | CEO | S - Sale | $71.56 | -11,046 | 24,175,756 | 0% | -$790,461 | ||||||
| M | 2020-07-22 | MRNA | Bancel Stephane | CEO | S - Sale | $80.98 | -19,000 | 24,186,802 | 0% | -$1,538,690 | |||||
| D | 2020-07-20 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $83.50 | -20,000 | 0 | -100% | -$1,669,956 | |||||
| M | 2020-07-17 | MRNA | Bancel Stephane | CEO | S - Sale | $86.48 | -17,372 | 23,709,716 | 0% | -$1,502,402 | |||||
| M | 2020-07-15 | MRNA | Bancel Stephane | CEO | S - Sale | $83.92 | -19,000 | 24,224,174 | 0% | -$1,594,460 | |||||
| D | 2020-07-15 | MRNA | Nabel Elizabeth G | Dir | S - Sale+OE | $87.84 | -73,975 | 0 | -100% | -$6,497,964 | |||||
| D | 2020-07-13 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $69.92 | -10,000 | 1,980,646 | -1% | -$699,237 | |||||
| A | 2020-03-13 | MRNA | Hoge Stephen | Pres | S - Sale | $22.43 | -1,110 | 2,046,733 | 0% | -$24,897 | |||||
| D | 2020-07-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $69.94 | -20,000 | 0 | -100% | -$1,398,744 | |||||
2020-07-10 | MRNA | Bancel Stephane | CEO | S - Sale | $63.85 | -20,281 | 15,076,870 | 0% | -$1,294,972 | ||||||
2020-07-09 | MRNA | Bancel Stephane | CEO | S - Sale | $62.04 | -10,000 | 24,264,455 | 0% | -$620,400 | ||||||
| DM | 2020-07-07 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $59.73 | -82,688 | 0 | -100% | -$4,939,096 | |||||
2020-07-06 | MRNA | Bancel Stephane | CEO | S - Sale | $59.53 | -11,046 | 24,275,455 | 0% | -$657,576 | ||||||
| D | 2020-07-06 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $58.48 | -10,000 | 1,980,656 | -1% | -$584,800 | |||||
| D | 2020-07-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $59.94 | -10,000 | 1,980,656 | -1% | -$599,400 | |||||
2020-07-02 | MRNA | Bancel Stephane | CEO | S - Sale | $59.94 | -10,000 | 24,287,501 | 0% | -$599,400 | ||||||
2020-07-01 | MRNA | Bancel Stephane | CEO | S - Sale | $62.92 | -18,344 | 24,297,501 | 0% | -$1,154,204 | ||||||
| D | 2020-06-30 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.00 | -39,752 | 0 | -100% | -$2,544,294 | |||||
2020-06-26 | MRNA | Bancel Stephane | CEO | S - Sale | $60.65 | -11,046 | 24,315,845 | 0% | -$669,892 | ||||||
2020-06-25 | MRNA | Bancel Stephane | CEO | S - Sale | $67.00 | -10,000 | 24,326,891 | 0% | -$670,000 | ||||||
| D | 2020-06-23 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $63.71 | -39,752 | 0 | -100% | -$2,532,720 | |||||
| M | 2020-06-23 | MRNA | Hoge Stephen | Pres | S - Sale | $64.24 | -10,000 | 1,980,656 | -1% | -$642,444 | |||||
2020-06-24 | MRNA | Bancel Stephane | CEO | S - Sale | $63.25 | -9,000 | 24,336,891 | 0% | -$569,250 | ||||||
2020-06-22 | MRNA | Bancel Stephane | CEO | S - Sale | $65.92 | -4,521 | 24,346,891 | 0% | -$298,024 | ||||||
2020-06-19 | MRNA | Bancel Stephane | CEO | S - Sale | $64.61 | -11,046 | 24,351,412 | 0% | -$713,715 | ||||||
| D | 2020-06-18 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale+OE | $63.03 | -64,000 | 681 | -99% | -$4,033,920 | |||||
| D | 2020-06-16 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $63.76 | -39,752 | 0 | -100% | -$2,534,618 | |||||
| M | 2020-06-12 | MRNA | Hoge Stephen | Pres | S - Sale | $63.32 | -10,000 | 1,990,656 | 0% | -$633,219 | |||||
2020-06-12 | MRNA | Bancel Stephane | CEO | S - Sale | $61.64 | -11,046 | 24,362,458 | 0% | -$680,849 | ||||||
2020-06-10 | MRNA | Bancel Stephane | CEO | S - Sale | $58.80 | -3,435 | 24,373,504 | 0% | -$201,978 | ||||||
| D | 2020-06-09 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $58.47 | -39,752 | 0 | -100% | -$2,324,364 | |||||
2020-06-05 | MRNA | Bancel Stephane | CEO | S - Sale | $57.85 | -11,046 | 24,376,939 | 0% | -$639,056 | ||||||
| AM | 2020-05-29 | MRNA | Bancel Stephane | CEO | S - Sale | $59.44 | -15,924 | 23,813,577 | 0% | -$946,591 | |||||
| A | 2020-05-12 | MRNA | Nabel Elizabeth G | Dir | S - Sale | $66.00 | -30,000 | 14,344 | -68% | -$1,980,000 | |||||
| A | 2020-05-20 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale | $70.00 | -64,000 | 0 | -100% | -$4,480,000 | |||||
| A | 2020-05-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $50.48 | -4,770 | 0 | -100% | -$240,790 | |||||
| A | 2020-05-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $78.16 | -125,044 | 0 | -100% | -$9,773,439 | |||||
| A | 2020-05-26 | MRNA | Hoge Stephen | Pres | S - Sale | $66.11 | -200 | 1,996,540 | 0% | -$13,222 | |||||
| A | 2020-05-01 | MRNA | Andres Juan | See remarks | S - Sale | $49.69 | -3,934 | 0 | -100% | -$195,480 | |||||
| A | 2020-05-13 | MRNA | Andres Juan | See remarks | S - Sale | $66.89 | -1,300 | 0 | -100% | -$86,957 | |||||
| A | 2020-05-15 | MRNA | Kim Lorence H. | CFO | S - Sale | $63.80 | -2,600 | 1,219,910 | 0% | -$165,880 | |||||
| A | 2020-05-20 | MRNA | Bancel Stephane | CEO | S - Sale | $70.00 | -12,558 | 9,198,717 | 0% | -$879,060 | |||||
| D | 2020-06-02 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $58.30 | -241,000 | 1,202,510 | -17% | -$14,050,300 | |||||
| D | 2020-06-02 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $58.32 | -98,956 | 0 | -100% | -$5,771,275 | |||||
| M | 2020-05-29 | MRNA | Bancel Stephane | CEO | S - Sale | $60.99 | -30,558 | 15,923,819 | 0% | -$1,863,704 | |||||
| D | 2020-05-27 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $51.13 | -241,000 | 1,202,510 | -17% | -$12,322,330 | |||||
| D | 2020-05-26 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $66.54 | -125,044 | 0 | -100% | -$8,320,428 | |||||
2020-05-26 | MRNA | Hoge Stephen | Pres | S - Sale | $61.85 | -10,000 | 2,000,656 | 0% | -$618,485 | ||||||
| M | 2020-05-21 | MRNA | Flagship Ventures Fund IV General Partner LLC | Dir, 10% | S - Sale | $68.22 | -1,000,000 | 19,274,952 | -5% | -$68,219,276 | |||||
2020-05-22 | MRNA | Bancel Stephane | CEO | S - Sale | $68.92 | -11,046 | 24,403,909 | 0% | -$761,250 | ||||||
| D | 2020-05-20 | MRNA | Henderson Lori M. | GC, Secretary | S - Sale+OE | $70.00 | -64,000 | 0 | -100% | -$4,480,000 | |||||
2020-05-20 | MRNA | Bancel Stephane | CEO | S - Sale | $70.00 | -16,744 | 16,530,075 | 0% | -$1,172,080 | ||||||
| D | 2020-05-19 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $78.16 | -125,044 | 0 | -100% | -$9,773,439 | |||||
| DM | 2020-05-15 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $80.85 | -261,000 | 1,202,510 | -18% | -$21,101,992 | |||||
2020-05-15 | MRNA | Bancel Stephane | CEO | S - Sale | $65.56 | -11,046 | 24,431,699 | 0% | -$724,200 | ||||||
| M | 2020-05-12 | MRNA | Hoge Stephen | Pres | S - Sale | $64.56 | -10,000 | 2,010,656 | 0% | -$645,615 | |||||
| D | 2020-05-13 | MRNA | Andres Juan | See remarks | S - Sale+OE | $64.67 | -127,500 | 0 | -100% | -$8,244,843 | |||||
| D | 2020-05-12 | MRNA | Kim Lorence H. | CFO | S - Sale+OE | $64.49 | -241,000 | 1,222,510 | -16% | -$15,541,142 | |||||
| D | 2020-05-12 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale+OE | $64.43 | -125,044 | 0 | -100% | -$8,055,981 | |||||
2020-05-12 | MRNA | Nabel Elizabeth G | Dir | S - Sale | $66.00 | -30,000 | 14,344 | -68% | -$1,980,000 | ||||||
| M | 2020-05-08 | MRNA | Bancel Stephane | CEO | S - Sale | $58.20 | -24,549 | 14,633,873 | 0% | -$1,428,758 | |||||
2020-05-05 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $50.48 | -4,770 | 0 | -100% | -$240,790 | ||||||
| D | 2020-05-01 | MRNA | Andres Juan | See remarks | S - Sale+OE | $48.05 | -25,000 | 0 | -100% | -$1,201,309 | |||||
2020-05-01 | MRNA | Bancel Stephane | CEO | S - Sale | $48.70 | -28,442 | 15,894,708 | 0% | -$1,385,125 | ||||||
| M | 2020-04-23 | MRNA | Hoge Stephen | Pres | S - Sale | $49.12 | -10,000 | 2,020,656 | 0% | -$491,232 | |||||
2020-04-24 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $47.15 | -10,000 | 4,770 | -68% | -$471,500 | ||||||
2020-04-24 | MRNA | Bancel Stephane | CEO | S - Sale | $47.15 | -11,046 | 24,441,745 | 0% | -$520,819 | ||||||
| M | 2020-04-17 | MRNA | Bancel Stephane | CEO | S - Sale | $45.53 | -28,122 | 15,903,406 | 0% | -$1,280,356 | |||||
2020-04-17 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $48.81 | -10,000 | 14,770 | -40% | -$488,100 | ||||||
| D | 2020-04-15 | MRNA | Andres Juan | See remarks | S - Sale+OE | $37.11 | -23,403 | 0 | -100% | -$868,448 | |||||
2020-04-15 | MRNA | Kim Lorence H. | CFO | S - Sale | $36.21 | -20,000 | 1,222,510 | -2% | -$724,230 | ||||||
2020-04-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $32.00 | -10,000 | 24,770 | -29% | -$320,000 | ||||||
2020-04-13 | MRNA | Hoge Stephen | Pres | S - Sale | $32.39 | -10,000 | 2,030,656 | 0% | -$323,898 | ||||||
2020-04-13 | MRNA | Bancel Stephane | CEO | S - Sale | $32.00 | -23,601 | 15,914,880 | 0% | -$755,232 | ||||||
| D | 2020-04-06 | MRNA | Andres Juan | See remarks | S - Sale+OE | $35.13 | -300 | 0 | -100% | -$10,539 | |||||
2020-04-03 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $32.81 | -10,000 | 34,770 | -22% | -$328,100 | ||||||
| D | 2020-04-03 | MRNA | Andres Juan | See remarks | S - Sale+OE | $35.09 | -13,697 | 0 | -100% | -$480,628 | |||||
2020-04-03 | MRNA | Bancel Stephane | CEO | S - Sale | $32.81 | -11,046 | 24,507,450 | 0% | -$362,419 | ||||||
2020-04-01 | MRNA | Bancel Stephane | CEO | S - Sale | $30.05 | -13,356 | 16,594,980 | 0% | -$401,348 | ||||||
2020-03-27 | MRNA | Bancel Stephane | CEO | S - Sale | $28.37 | -11,046 | 24,531,852 | 0% | -$313,375 | ||||||
2020-03-27 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $28.37 | -10,000 | 44,770 | -18% | -$283,700 | ||||||
| M | 2020-03-23 | MRNA | Hoge Stephen | Pres | S - Sale | $26.58 | -10,000 | 2,040,656 | 0% | -$265,812 | |||||
2020-03-20 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $29.13 | -10,000 | 54,770 | -15% | -$291,300 | ||||||
2020-03-20 | MRNA | Bancel Stephane | CEO | S - Sale | $29.13 | -25,195 | 15,927,836 | 0% | -$733,930 | ||||||
| DM | 2020-03-17 | MRNA | Andres Juan | See remarks | S - Sale+OE | $31.25 | -31,598 | 0 | -100% | -$987,365 | |||||
2020-03-16 | MRNA | Kim Lorence H. | CFO | S - Sale | $26.19 | -20,000 | 1,242,510 | -2% | -$523,819 | ||||||
2020-03-13 | MRNA | Bancel Stephane | CEO | S - Sale | $21.17 | -11,046 | 24,568,093 | 0% | -$233,857 | ||||||
2020-03-13 | MRNA | Zaks Tal Zvi | Chief Medical Officer | S - Sale | $23.00 | -10,000 | 64,770 | -13% | -$230,000 | ||||||
| M | 2020-03-12 | MRNA | Hoge Stephen | Pres | S - Sale | $22.06 | -9,990 | 2,050,656 | 0% | -$220,366 | |||||
2020-03-09 | MRNA | Lee Jennifer Ling | Chief Accounting Officer | S - Sale | $27.33 | -361 | 4,419 | -8% | -$9,866 | ||||||
2020-03-10 | MRNA | Bancel Stephane | CEO | S - Sale | $25.71 | -16,468 | 16,646,546 | 0% | -$423,392 | ||||||
| D | 2020-03-09 | MRNA | Andres Juan | See remarks | S - Sale+OE | $30.00 | -104 | 0 | -100% | -$3,120 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |